Rob Glynne‐Jones
Rob Glynne‐Jones publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Colorectal and Anal Carcinomas, Colorectal Cancer Surgical Treatments and Colorectal Cancer Treatments and Studies.
- World rank
- #143,120 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #12,936 of 367,258
- Works
- 340
- Citations
- 21k
- Citations per work
- 62.9
What does Rob Glynne‐Jones research?
Rob Glynne‐Jones's work is mostly in Medicine (89%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences30188.6%
- Medicine30188.6%
- Everything else3911.4%
- 1Oncology36% of their works
- 2Surgery33% of their works
- 3Pulmonary and Respiratory Medicine11% of their works
- 4Radiology, Nuclear Medicine and Imaging4% of their works
- 5Pathology and Forensic Medicine2% of their works
- 6Epidemiology2% of their works
Research topics
- Colorectal and Anal Carcinomas
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Screening and Detection
- Anorectal Disease Treatments and Outcomes
- Radiomics and Machine Learning in Medical Imaging
- Esophageal Cancer Research and Treatment
Which keywords describe Rob Glynne‐Jones's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Chemoradiation, Anal Cancer, Intensity-Modulated Radiation Therapy, Neoadjuvant Therapy, Preoperative Chemoradiotherapy and Adjuvant Chemotherapy.
- Medical Imaging
- Barrett's Esophagus
- Fistulas
- Colorectal Cancer
- Gastric Cancer
- Endoscopic Resection
- Precision Medicine
- Adjuvant Chemotherapy
- Neoadjuvant Therapy
- Anal Cancer
- Clinical Practice Guidelines
- Chemotherapy
- Chemoradiation
- Intensity-Modulated Radiation Therapy
- Preoperative Chemoradiotherapy
- Rectal Cancer
- Cetuximab
- KRAS Mutations
- Molecular Characterization
- Screening
- Hemorrhoids
- Esophageal Carcinoma
- Radiomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Chemotherapy3513 topics
- Clinical Practice Guidelines2442 topics
- Chemoradiation2272 topics
- Anal Cancer2071 topic
- Intensity-Modulated Radiation Therapy2071 topic
- Neoadjuvant Therapy2022 topics
- Preoperative Chemoradiotherapy2022 topics
- Adjuvant Chemotherapy1821 topic
- Rectal Cancer1821 topic
- Precision Medicine1022 topics
- Cetuximab821 topic
- Endoscopic Resection822 topics
- KRAS Mutations821 topic
- Gastric Cancer621 topic
- Molecular Characterization621 topic
- Colorectal Cancer471 topic
- Screening471 topic
- Fistulas311 topic
- Hemorrhoids311 topic
- Barrett's Esophagus201 topic
- Esophageal Carcinoma201 topic
- Medical Imaging201 topic
- Radiomics201 topic
Where does Rob Glynne‐Jones work?
Rob Glynne‐Jones's main affiliation in the publication record is Mount Vernon Cancer Centre, United Kingdom.
How many publications and citations does Rob Glynne‐Jones have?
OpenAlex counts 340 works and 21,370 citations for Rob Glynne‐Jones, an h-index of 66, ranking #143,120 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Rob Glynne‐Jones
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rob Glynne‐Jones. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.